- $2.2 BnWorld market, 2023
- $23.5 BnProjected, 2033
- 26.7%Growth a year (CAGR)
- 2,210Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$924 Mn
24.7% a year · 42% of the world -
2
China
$177 Mn
28.2% a year · 8% of the world -
3
Canada
$176 Mn
26.7% a year · 8% of the world -
4
Japan
$137 Mn
27.2% a year · 6.2% of the world -
5
Germany
$81 Mn
24.9% a year · 3.7% of the world -
6
France
$61 Mn
25.7% a year · 2.8% of the world -
7
UK
$57 Mn
24.7% a year · 2.6% of the world -
8
Brazil
$55 Mn
27.7% a year · 2.5% of the world -
9
Italy
$53 Mn
26.2% a year · 2.4% of the world -
10
Ecuador
$44 Mn
27.3% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
Spain
EgyptArtificial Intelligence (AI) in Life Sciences by country and region
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Philippines
Hong Kong
Malaysia
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 11,749 papers since 2021
- Toward a unified computational representation of lung cancer: from radiomics and pathomics to multimodal AI. Clinical imaging, 2026
- Senescence-targeted engineered CAR-T immunotherapy: advances, challenges and perspectives for engineered senolytic immunotherapy. EBioMedicine, 2026
- Redefining Success in Cancer Care: A Meaningful-Life-Centred Framework for Precision Medicine. Journal of evaluation in clinical practice, 2026
- Graphics processing unit-accelerated quantum simulation for molecular biology and drug discovery: algorithms, platforms, and emerging applications. Briefings in bioinformatics, 2026
- Rare genetic variants in leber hereditary optic neuropathy: molecular mechanisms, diagnosis, and emerging therapies. Documenta ophthalmologica. Advances in ophthalmology, 2026
Compare Artificial Intelligence (AI) in Life Sciences side by side
Key companies in Artificial Intelligence (AI) in Life Sciences
IBM Watson Health
Google Health
Microsoft Healthcare
Amazon Web Services (AWS)
NVIDIA Corporation
GE Healthcare
Siemens Healthineers
Philips Healthcare
Medtronic
Intel Corporation
Quick answers
How big is the Artificial Intelligence (AI) in Life Sciences market?
The world Artificial Intelligence (AI) in Life Sciences market was worth about $2.2 Bn in 2023 and is projected to reach $23.5 Bn by 2033, growing 26.7% a year (CAGR).
Which country has the largest Artificial Intelligence (AI) in Life Sciences market?
The US is the largest of the 24 countries we cover, at $924 Mn in 2023. India grows fastest, at 29.7% a year.
How many clinical trials are running in Artificial Intelligence (AI) in Life Sciences?
ClinicalTrials.gov lists 2,210 active trials worldwide (recruiting, about to start or running), most of them in China, as of 10 Nov 2026.
How much research is published on Artificial Intelligence (AI) in Life Sciences?
PubMed lists about 11,749 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.